The use of durvalumab following definitive chemo-radiotherapy in unresectable stage III non-small-cell lung cancer - An experience of the Northern Adelaide Cancer Centre

被引：0
|
作者：
Penumarty, Rama Devi [1 ]
Forgione, Michelle [1 ]
Patel, Dainik [1 ]
Hocking, Christopher [1 ]
Joshi, Rohit [1 ]
Kwatra, Vineet [1 ]
机构：
[1] Northern Adelaide Local Hlth Network, Med Oncol, Elizabeth Vale, SA, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
256
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [1] Durvalumab after chemo-radiotherapy in stage III non-small cell lung cancer
    Chiramel, Jaseela
    Tay, Rebecca
    Califano, Raffaele
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S991 - S994
  • [2] Chemo-radiotherapy before surgery in stage III non-small-cell lung cancer
    Bonnette, P.
    REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (02) : 105 - 114
  • [3] Prognosis Impact of Oligoprogression Following Definitive Chemo-Radiotherapy in Stage III Non-Small Cell Lung Cancer
    Saigi, Maria
    Rullan, Aj
    Bergamino Sirven, Milana
    Navarro-Martin, Arturo
    Dolores Arnaiz, Ma
    Palmero, Ramon
    Plana, Maria
    Carlos Ruffinelli, Jose
    Mesia, Caries
    Padrones, Susana
    Aso, Samantha
    Brao, Isabel
    Arellano, Monica
    Saldana, Joana
    Navarro, Valentin
    Cardenal, Felipe
    Nadal, Ernest
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S851 - S852
  • [4] Pleural effusion in patients receiving definitive chemo-radiotherapy followed by durvalumab immunotherapy for stage III non-small cell lung cancer
    Yong, Wee Siang
    Nguyen, Thu
    Roberts-Thomson, Rachel
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 50 - 51
  • [5] Chemo-radiotherapy integration in unresectable locally advanced non-small-cell lung cancer: a review
    Baldini, E.
    Tibaldi, C.
    Delli Paoli, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (10): : 1681 - 1686
  • [6] Chemo-radiotherapy integration in unresectable locally advanced non-small-cell lung cancer: a review
    E. Baldini
    C. Tibaldi
    C. Delli Paoli
    Clinical and Translational Oncology, 2020, 22 : 1681 - 1686
  • [7] Recurrence pattern and its prognostic impact following definitive chemo-radiotherapy in stage III non-small cell lung cancer
    Saigi Morgui, M.
    Rullan Iriarte, A. J.
    Bergamino, M.
    Navarro, A.
    Arnaiz, M. M.
    Palmero, R.
    Plana Serrahima, M.
    Mesia, C.
    Padrones, S.
    Aso, S.
    Ruffinelli Rodriguez, J.
    Navarro, V.
    Brao, I.
    Nadal, E.
    Cardenal Alemany, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Durvalumab in Stage III Non-Small-Cell Lung Cancer
    Copur, Mehmet S.
    Gauchan, Dron
    Ramaekers, Ryan
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09): : 868 - 868
  • [9] Cost-effectiveness of consolidation durvalumab after chemo-radiotherapy in stage III non-small-cell lung cancer: A cost-effective change Comment
    Giuliani, Jacopo
    Infante, Valentino
    Micheletto, Claudio
    Bonetti, Andrea
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 438 - 441
  • [10] Chemo-radiotherapy for stage III unresectable non-small cell lung cancer - long-term results of a prospective study
    Leong, SS
    Fong, KW
    Ong, YK
    Foo, KF
    Ang, P
    Wee, J
    Lee, KM
    Tan, EH
    RESPIRATORY MEDICINE, 2004, 98 (11) : 1080 - 1086
12345